Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review

@inproceedings{Miller2011SecondGenerationAD,
  title={Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review},
  author={Brian John Miller and Chelsea M Bodenheimer and Krystle Crittenden},
  booktitle={Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology},
  year={2011}
}
"All-causes discontinuation" refers to discontinuation of treatment for any reason, and medication adherence is an important component of this measure. Similar to our previous results, we found that almost 30% of patients with first-episode psychosis (FEP) discontinue medication in the first 9 months of treatment, a finding that has important implications for long-term outcomes. Many newer second-generation antipsychotics have not been studied in FEP. The self-reported Drug Attitude Inventory… CONTINUE READING
Highly Cited
This paper has 31 citations. REVIEW CITATIONS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
7 Extracted Citations
31 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 31 references

A review of second-generation antipsychotic discontinuation in first-episode psychosis

  • BJ Miller
  • J Psychiatr Pract 2008;14:289-300
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…